The interest in Cannabis sativa L. phytocomplex as a medicinal tool is a recently-emerging topic. Neurodegenerative diseases represent a promising field of application for cannabis and its preparations, as most of this pathologic conditions relies on an inflammatory etiology. Several cannabis constituents display anti-inflammatory effects targeting multiple pathways. In this review, a comprehensive overview of the available literature on C sativa constituents activities in neuroinflammation is given. On the basis that the anti-inflammatory activity of cannabis is not attributable to only a single constituent, we discuss the possible advantages of administering the whole phytocomplex in order to fully exploit the “entourage effect” in neuroinflammatory-related conditions.
|Titolo:||Cannabis sativa L. constituents and their role in neuroinflammation|
GOVERNA, PAOLO (Corresponding)
|Citazione:||Borgonetti, V., Governa, P., Montopoli, M., & Biagi, M. (2019). Cannabis sativa L. constituents and their role in neuroinflammation. CURRENT BIOACTIVE COMPOUNDS, 15(2), 147-158.|
|Appare nelle tipologie:||1.1 Articolo in rivista|